These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 26481366)

  • 41. Concurrent chemoradiotherapy for large-volume locally-advanced non-small cell lung cancer.
    Wiersma TG; Dahele M; Verbakel WF; van de Ven PM; de Haan PF; Smit EF; van Reij EJ; Slotman BJ; Senan S
    Lung Cancer; 2013 Apr; 80(1):62-7. PubMed ID: 23357464
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the National Cancer Data Base.
    Wong AT; Shao M; Rineer J; Osborn V; Schwartz D; Schreiber D
    Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27860114
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Triple-modality treatment in patients with advanced stage tonsil cancer.
    Roden DF; Schreiber D; Givi B
    Cancer; 2017 Sep; 123(17):3269-3276. PubMed ID: 28440876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer.
    Torgeson A; Lloyd S; Boothe D; Tao R; Whisenant J; Garrido-Laguna I; Cannon GM
    Cancer; 2017 Oct; 123(19):3816-3824. PubMed ID: 28621885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A retrospective evaluation of therapeutic efficacy and safety of chemoradiotherapy in older patients (aged ≥ 75 years) with limited-disease small cell lung cancer: insights from two institutions and review of the literature.
    Shiono A; Imai H; Endo S; Katayama K; Sato H; Hashimoto K; Miura Y; Okazaki S; Abe T; Mouri A; Kaira K; Masubuchi K; Kobayashi K; Minato K; Kato S; Kagamu H
    Radiol Oncol; 2024 Sep; 58(3):432-443. PubMed ID: 39287161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Addition of chemotherapy to definitive radiotherapy for IB1 and IIA1 cervical cancer: Analysis of the National Cancer Data Base.
    Haque W; Verma V; Fakhreddine M; Hatch S; Butler EB; Teh BS
    Gynecol Oncol; 2017 Jan; 144(1):28-33. PubMed ID: 27784533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients.
    Fiteni F; Vernerey D; Bonnetain F; Vaylet F; Sennélart H; Trédaniel J; Moro-Sibilot D; Herman D; Laizé H; Masson P; Derollez M; Clément-Duchêne C; Milleron B; Morin F; Zalcman G; Quoix E; Westeel V
    Eur J Cancer; 2016 Jan; 52():120-8. PubMed ID: 26682871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patterns of Care and Outcomes of Hypofractionated Chemoradiation Versus Conventionally Fractionated Chemoradiation for Glioblastoma in the Elderly Population.
    Haque W; Verma V; Butler EB; Teh BS
    Am J Clin Oncol; 2018 Feb; 41(2):167-172. PubMed ID: 29369825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved survival with combined modality therapy in the modern era for primary mediastinal B-cell lymphoma.
    Jackson MW; Rusthoven CG; Jones BL; Kamdar M; Rabinovitch R
    Am J Hematol; 2016 May; 91(5):476-80. PubMed ID: 26852276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical outcomes and synergistic effect between radiotherapy and immunotherapy in patients with extensive-stage small cell lung cancer: a real-world study.
    Sun M; Ji H; Deng F; Li J; Xu N; Li Y
    BMC Cancer; 2024 Sep; 24(1):1206. PubMed ID: 39350057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma.
    Hsu PK; Huang CS; Wang BY; Wu YC; Hsu WH
    Ann Thorac Surg; 2014 May; 97(5):1734-41. PubMed ID: 24612702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sequential Versus Concurrent Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for N3 Limited-Stage Small-Cell Lung Cancer.
    Wang Z; Wan J; Liu C; Li L; Dong X; Geng H
    Cancer Control; 2020; 27(1):1073274820956619. PubMed ID: 32951452
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.
    Amini A; Jones BL; McDermott JD; Serracino HS; Jimeno A; Raben D; Ghosh D; Bowles DW; Karam SD
    Cancer; 2016 May; 122(10):1533-43. PubMed ID: 26969811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis.
    Rodrigues G; Oberije C; Senan S; Tsujino K; Wiersma T; Moreno-Jimenez M; Kim TH; Marks LB; Rengan R; De Petris L; Ramella S; DeRuyck K; De Dios NR; Warner A; Bradley JD; Palma DA
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):133-9. PubMed ID: 25835622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0-2) Non-Small-Cell Lung Cancer Is Dependent on Pathologic Nodal Response.
    Ziel E; Hermann G; Sen N; Bonomi P; Liptay MJ; Fidler MJ; Batus M; Warren WH; Chmielewski G; Sher DJ
    J Thorac Oncol; 2015 Oct; 10(10):1475-80. PubMed ID: 26398822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemoradiotherapy for limited-disease small-cell lung cancer in elderly patients aged 75 years or older.
    Shukuya T; Takahashi T; Harada H; Ono A; Akamatsu H; Taira T; Kenmotsu H; Naito T; Murakami H; Endo M; Takahashi K; Yamamoto N
    Jpn J Clin Oncol; 2013 Feb; 43(2):176-83. PubMed ID: 23225910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy.
    Koo TR; Moon SH; Lim YJ; Kim JY; Kim Y; Kim TH; Cho KH; Han JY; Lee YJ; Yun T; Kim HT; Lee JS
    Radiat Oncol; 2014 Dec; 9():283. PubMed ID: 25498887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concurrent chemoradiotherapy with weekly nedaplatin versus radiotherapy alone in elderly patients with non-small-cell lung cancer.
    Chen F; Hu P; Liang N; Xie J; Yu S; Tian T; Zhang J; Deng G; Zhang J
    Clin Transl Oncol; 2018 Mar; 20(3):294-301. PubMed ID: 28741074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy.
    Roengvoraphoj O; Eze C; Niyazi M; Li M; Hildebrandt G; Fietkau R; Belka C; Manapov F
    Strahlenther Onkol; 2017 Feb; 193(2):150-155. PubMed ID: 27853828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patterns of care and outcomes for use of concurrent chemoradiotherapy over radiotherapy alone for anaplastic gliomas.
    Yeboa DN; Rutter CE; Park HS; Lester-Coll NH; Corso CD; Mancini BR; Bindra RS; Contessa J; Yu JB
    Radiother Oncol; 2017 Nov; 125(2):258-265. PubMed ID: 29054377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.